Toshiyuki Yano - Concepedia

Author

Toshiyuki Yano

Also Known As

T YANO, T Yano, T. Yano, TOSHIYUKI YANO, Tomohisa Yamashita, Tomonori Yano, Toshiyuki YANO, Toshiyuki Yano, Toshiyuki Yano (317465), Yano, Toshiyuki

236

Publications

4.4K

Citations

H-Index

108

Concepts

All Affiliations

Sapporo Medical University Sapporo Medical University Hospital Cardiovascular Center Hokkaido Ohno Hospital Kumamoto University Hospital Hokkaido University of Science

About

Toshiyuki Yano is an author at Sapporo Medical University specializing in medicine, cardiology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.3K
2	Health Sciences	2	2	230
3	Natural Sciences	2	2	264
4	Engineering	1	1	15
5	Management	1	1	15

Toshiyuki Yano

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure Masaya Tanno, Atsushi Kuno, Toshiyuki Yano, Journal of Biological Chemistry	2010	349
Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection Masahiro Nishihara, Tetsuji Miura, Takayuki Miki, Journal of Molecular and Cellular Cardiology Cardiac MuscleSignal TransductionMitochondrial FunctionBiochemistryNatural Sciences	2007	226
Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts Masashi Mizuno, Atsushi Kuno, Toshiyuki Yano, Physiological Reports Heart FailureLipid DropletsMitochondrial SizeRat ModelOxidative Stress	2018	165
Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3β–Mediated Suppression of Mitochondrial Permeability Transition Takayuki Miki, Tetsuji Miura, Hiroyuki Hotta, Diabetes	2009	120
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats H Oshima, Takayuki Miki, Atsushi Kuno, Journal of Pharmacology and Experimental Therapeutics	2018	119
JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis Toshiyuki Nagai, Takayuki Inomata, Takashi Kohno, Circulation Journal Structural Heart DiseaseCardiovascular DiseaseCardiac PathologyCardiac CarePericardial Disease	2023	100
Protective role of gap junctions in preconditioning against myocardial infarction Tetsuji Miura, Yoshito Ohnuma, Atsushi Kuno, American Journal of Physiology-Heart and Circulatory Physiology	2004	90
Translocation of Glycogen Synthase Kinase-3β (GSK-3β), a Trigger of Permeability Transition, Is Kinase Activity-dependent and Mediated by Interaction with Voltage-dependent Anion Channel 2 (VDAC2) Masaya Tanno, Atsushi Kuno, Satoko Ishikawa, Journal of Biological Chemistry	2014	90
Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair Toshiyuki Yano, Tetsuji Miura, Yoshihiro Ikeda, Cardiovascular Pathology Cardiac MuscleCardiomyopathyMyocardial Infarct RepairMyocardial InfarctionIntracardiac Fibroblasts	2005	89
Neuroprotective Effect of Urinary Trypsin Inhibitor against Focal Cerebral Ischemia–Reperfusion Injury in Rats Toshiyuki Yano, Sakiko Anraku, Ryosuke Nakayama, Anesthesiology	2003	89

Page 1